Company: DHR
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0000313616-25-000043
Chunk: 234

Company: DANAHER CORP /DE/
Filing Date: 2025-02-20
Form: 10-K
Item: Item 5
Chunk 234
---
 the Company’s debt as of December 31 were as follows (amounts in millions):Outstanding AmountDescription and Aggregate Principal Amount20242023Euro-denominated commercial paper (€931 million and €929 million, respectively)(e)$965 $1,026 1.7% senior unsecured notes due 3/30/2024 (€900 million) (the “2024 Euronotes”)(f)— 993 2.2% senior unsecured notes due 11/15/2024 ($700 million) (the “2024 Biopharma Notes”)(b)— 699 3.35% senior unsecured notes due 9/15/2025 ($500 million) (the “2025 U.S. Notes”)(f)500 499 0.2% senior unsecured notes due 3/18/2026 (€1.3 billion) (the “2026 Biopharma Euronotes”)(b)1,293 1,376 2.1% senior unsecured notes due 9/30/2026 (€800 million) (the “2026 Euronotes”)(f)828 881 0.3% senior unsecured notes due 5/11/2027 (¥30.8 billion) (the “2027 Yen Notes”)(d)195 218 1.2% senior unsecured notes due 6/30/2027 (€600 million) (the “2027 Euronotes”)(a)620 660 0.45% senior unsecured notes due 3/18/2028 (€1.3 billion) (the “2028 Biopharma Euronotes”)(b)1,291 1,374 1.125% senior unsecured bonds due 12/08/2028 (CHF 210 million) (the “2028 CHF Bonds”)(c)233 252 2.6% senior unsecured notes due 11/15/2029 ($800 million) (the “2029 Biopharma Notes”)(b)797 797 2.5% senior unsecured notes due 3/30/2030 (€800 million) (the “2030 Euronotes”)(f)829 883 0.75% senior unsecured notes due 9/18/2031 (€1.8 billion) (the “2031